Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
Source: CPSC Recall #22754
Recall Date
2022-06-30
Manufacturer
Mohnark Pharmaceuticals Inc., of Davie, Fla.
Units Affected
About 9,000
Products Involved
Lidocaine 4% Topical Anesthetic Cream
Hazard
The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
Remedy
Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
Reported Injuries
None reported
Sold At
Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7.
Manufactured In
United States
Full Recall Description
The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.
Data source: U.S. Consumer Product Safety Commission (CPSC) via SaferProducts.gov.
For the most current recall information, check directly with CPSC or the manufacturer.
Last verified: 2026-03-28